Teva partners Israeli universities for new cancer treatments

Israel’s Teva and Tel Aviv University have signed an R&D agreement in the fields of cancer and brain studies. Teva has also partnered with Israel’s Weizmann Institute to identify the next generation of innovative antibodies for cancer treatment.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *